The trading price of ATAI Life Sciences N.V. (NASDAQ:ATAI) floating lower at last check on Monday, April 01, closing at $1.80, -8.38% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $2.39 and a 52-week low of $1.02. Over the past month, the stock has lost -6.96% in value.
ATAI Life Sciences N.V., whose market valuation is $299.65 million at the time of this writing, is expected to release its quarterly earnings report Mar 19, 2024 – Mar 26, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.16 per share this quarter, however they have predicted annual earnings per share of -$0.7 for 2024 and -$0.69 for 2025. It means analysts are expecting annual earnings per share growth of -180.00% this year and 1.40% next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $300k. The company’s revenue is forecast to drop by -4.50% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of ATAI Life Sciences N.V. 1 upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ATAI has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that ATAI’s price is currently -3.01% off the SMA20 and -1.69% off the SMA50. The RSI metric on the 14-day chart is currently showing 49.51, and weekly volatility stands at 7.71%. When measured over the past 30 days, the indicator reaches 8.89%. ATAI Life Sciences N.V. (NASDAQ:ATAI)’s beta value is currently sitting at 0.98, while the Average True Range indicator is currently displaying 0.15.
To see how ATAI Life Sciences N.V. stock has been performing today in comparison to its peers in the industry, here are the numbers: ATAI stock’s performance was -8.38% at last check in today’s session, and 13.52% in the past year.
An evaluation of the daily trading volume of ATAI Life Sciences N.V. (NASDAQ:ATAI) indicates that the 3-month average is 1.54 million. However, this figure has increased over the past 10 days to an average of 1.38 million.
Currently, records show that 166.03 million of the company’s shares remain outstanding. The insiders hold 30.51% of outstanding shares, whereas institutions hold 8.23%. The stats also highlight that short interest as of Mar 15, 2024, stood at 5.21 million shares, resulting in a short ratio of 3.34 at that time. From this, we can conclude that short interest is 3.14% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 4.87 million. However, since the stock’s price has seen 28.01% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
